Defence Therapeutics Inc.
DTC
Rangering i aksjer
#29781
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aksjekurs
$0.24953854
Sist synkronisert: 2026-10-16
Markedsverdi
$18.91M
Endring (1 dag)
-5.56%
Endring (1 år)
-53.23%
Land
CA
Handel Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Markedsverdi av Defence Therapeutics Inc.(DTC)
Markedsverdi: $18.91M
Per October 2026 har Defence Therapeutics Inc. en markedsverdi på $18.91M. Dette gjør Defence Therapeutics Inc. til det 29781st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Defence Therapeutics Inc. fra 2021 til 2026
DTC sammenlignet med topp 5 mest populære stocks
